Diabetic Pet Glucose Control via Natural Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for managing diabetes in humans and animals, particularly type II diabetes, often fail to provide optimal control of blood glucose levels and are associated with significant side effects and logistical challenges, such as the need for frequent insulin administration and rigid dietary restrictions.
Innovation Solution
A composition comprising bran, cinnamon, yeast, gelatin, and optionally wheat germ oil, octacosanol, and flavor, administered to reduce blood glucose levels, which can be in the form of treats, kibble, bars, or shakes, and may include chromium-enhanced yeast, designed to improve insulin sensitivity and stabilize glucose levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If insulin or medications are administered to control blood glucose levels, then blood glucose control is improved, but negative side effects increase
Solution Approach 1:
The patent uses a natural composition containing cinnamon, bran, yeast, gelatin, and wheat germ oil as an intermediary substance to modulate blood glucose levels. This natural mixture acts as a mediator between dietary intake and blood glucose regulation, providing glycemic control without the harsh side effects of synthetic insulin or medications. The composition works through natural mechanisms including fiber slowing glucose absorption, chromium enhancing insulin sensitivity, and antioxidants reducing oxidative stress.
Solution Approach 2:
The patent changes the approach to blood glucose control by using natural compounds that work through multiple physiological parameters simultaneously. The composition affects insulin sensitivity, glucose absorption rate, oxidative stress levels, and inflammatory markers. By modifying these multiple parameters through natural ingredients, the patent achieves blood glucose control while avoiding the narrow, high-risk parameter manipulation of synthetic medications.
2Reliability
If insulin injections are administered, then blood glucose levels are controlled, but treatment complexity and time commitment increase
Solution Approach 1:
The patent transforms blood glucose control from an externally administered treatment requiring frequent medical intervention into a self-service solution through dietary supplementation. The natural composition is incorporated into the animal's regular food intake, eliminating the need for owners to perform insulin injections, monitor blood glucose frequently, or adjust dosages. The composition works passively through natural metabolic pathways, allowing the animal's own body to regulate glucose levels with minimal external input.
Solution Approach 2:
Instead of using synthetic medications to force blood glucose control, the patent inverts the approach by using natural dietary components that work with the body's existing metabolic systems. Rather than introducing foreign substances that override natural regulation, the composition enhances and supports the body's inherent glucose management mechanisms through chromium-enhanced insulin sensitivity and fiber-mediated glucose absorption modulation.
3Reliability
If rigid dietary restrictions are imposed, then blood glucose control is improved, but ease of operation decreases
Solution Approach 1:
The patent creates a universal dietary supplement that can be incorporated into various food types and feeding routines. The natural composition works across different dietary preferences and food formulations, eliminating the need for strict dietary restrictions. It can be mixed with regular pet food, treats, or specialized diets, providing blood glucose control benefits regardless of the base diet composition. This multi-functionality allows flexible integration into existing feeding routines without requiring owners to implement rigid dietary protocols.
Data Source
AI summary
The present invention relates to a composition and method for reducing blood glucose levels in a mammal, such as canines and humans. The composition includes bran, cinnamon, yeast, gelatin, and optionally, wheat germ oil, octacosanol, and/or flavor. The method includes administering the composition to the mammal and, if the composition lacks wheat germ oil, also administering wheat germ oil to the mammal.